Researchers found that hereditary cancer testing can significantly impact your health decisions. Actress Jackie Tohn shared her personal experience with the MyRisk® Hereditary Cancer Test after discovering she carried a BRCA1 gene variant linked to a high risk of breast and ovarian cancers. With this knowledge, she opted for preventive surgeries, emphasizing that such testing can empower individuals to take proactive steps in managing their health risks.

This discovery is particularly relevant for people with a family history of cancer, especially if multiple relatives have been diagnosed with the same type of cancer or if cancers were diagnosed at a young age. For individuals of Ashkenazi Jewish ancestry, the risk is even higher, with 1 in 40 carrying a BRCA1/2 mutation. Knowing your hereditary risk can lead to personalized health plans that may include increased screenings or preventive measures, potentially saving lives.

The MyRisk test evaluates 63 genes associated with 11 cancer types, including breast and ovarian cancers. While Tohn’s story highlights the importance of genetic testing, it is essential to note that this is not a one-size-fits-all solution. The test can be completed through a healthcare provider, and results are typically available within 14 days. Myriad Genetics, the company behind the test, has been a leader in hereditary cancer testing for over 30 years, providing valuable insights for over 3 million patients.

If you’re curious about your hereditary cancer risk, consider discussing your family health history with your doctor and exploring genetic testing options like the MyRisk test. Understanding your risk can help you make informed decisions about your health.

Source: globenewswire.com